Giles Richard Platford
CIK: 0001977620
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Platford Giles Richard
Platford Giles Richard (SEC CIK 0001977620) files insider reports with the SEC as President, IBU of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 4 ownership filings by Platford Giles Richard (1 Form 3, 3 Form 4), filed between Mar 18, 2026 and Aug 12, 2026. Those filings report 3 transactions, from Apr 27, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Platford Giles Richard's filings is in CAMBRIDGE, MA.
Recent filings by Platford Giles Richard
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit